Search Results

There are 21930 results for: content related to: Myelodysplastic Syndromes: The Role of Cytogenetic and Molecular Abnormalities for Classification and Risk Assignment

  1. Myelodysplastic Syndromes

    Cancer Cytogenetics, THIRD EDITION

    Sverre Heim, Felix Mitelman, Pages: 141–178, 2010

    Published Online : 4 OCT 2010, DOI: 10.1002/9781118010136.ch6

  2. The Myelodysplastic Syndromes

    Leukaemia Diagnosis, Fourth Edition

    Barbara J. Bain, Pages: 219–260, 2010

    Published Online : 30 JUN 2010, DOI: 10.1002/9781444318470.ch4

  3. You have free access to this content
    The myelodysplastic syndromes: the era of understanding

    European Journal of Haematology

    Volume 94, Issue 5, May 2015, Pages: 379–390, Stef Meers

    Version of Record online : 1 OCT 2014, DOI: 10.1111/ejh.12443

  4. Myelodysplastic Syndromes

    Veterinary Comparative Hematopathology

    Victor E. Valli, Pages: 473–489, 2008

    Published Online : 30 JAN 2008, DOI: 10.1002/9780470344545.ch8

  5. Myelodysplastic Syndromes

    Leukemias: Principles and Practice of Therapy

    William Stevenson, Guillermo Garcia-Manero, Pages: 99–114, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch8

  6. Myelodysplasia

    Pathy's Principles and Practice of Geriatric Medicine, Volume 1 & 2, Fifth Edition

    Martha Wadleigh, David S. Rosenthal, Richard M. Stone, Pages: 363–374, 2012

    Published Online : 12 MAR 2012, DOI: 10.1002/9781119952930.ch32

  7. You have free access to this content
    Molecular and genetic features of myelodysplastic syndromes

    International Journal of Laboratory Hematology

    Volume 34, Issue 3, June 2012, Pages: 215–222, P. L. GREENBERG

    Version of Record online : 27 DEC 2011, DOI: 10.1111/j.1751-553X.2011.01390.x

  8. You have free access to this content
    Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on a series of 56 patients

    Cytometry Part B: Clinical Cytometry

    Volume 78B, Issue 3, May 2010, Pages: 154–168, Sergio Matarraz, Antonio López, Susana Barrena, Carlos Fernandez, Evan Jensen, Juan Flores-Montero, Ana Rasillo, José María Sayagues, Maria Luz Sánchez, Paloma Bárcena, Jesús María Hernandez-Rivas, Carlos Salvador, Nuria Fernandez-Mosteirín, Manuel Giralt, Luis Perdiguer, Paula Laranjeira, Artur Paiva and Alberto Orfao

    Version of Record online : 2 MAR 2010, DOI: 10.1002/cyto.b.20513

  9. Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond—9th European Hematology Association Congress Geneva, Switzerland, 10–13 June 2004

    Transfusion Medicine

    Volume 17, Issue 3, June 2007, Pages: 151–160, P. Fenaux, J. M. Bennett, D. T. Bowen, R. D. Knight and A. F. List

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1365-3148.2006.00681.x

  10. Myelodysplastic Syndromes

    Leukaemia Diagnosis, Third Edition

    Barbara J. Bain, Pages: 144–179, 2007

    Published Online : 12 NOV 2007, DOI: 10.1002/9780470988374.ch3

  11. Myelodysplastic Disorders

    Laboratory Hematology Practice

    Maryalice Stetler-Stevenson, Joseph A. DiGiuseppe, Diane C. Arthur, Pages: 331–344, 2012

    Published Online : 8 AUG 2012, DOI: 10.1002/9781444398595.ch25

  12. You have free access to this content
    Update on the therapy for myelodysplastic syndrome

    American Journal of Hematology

    Volume 84, Issue 3, March 2009, Pages: 177–186, Margaret T. Kasner and Selina M. Luger

    Version of Record online : 15 DEC 2008, DOI: 10.1002/ajh.21352

  13. You have free access to this content
    Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy

    British Journal of Haematology

    Volume 153, Issue 5, June 2011, Pages: 568–581, Shikhar Aggarwal, Arjan A. van de Loosdrecht, Canan Alhan, Gert J. Ossenkoppele, Theresia M. Westers and Hetty J. Bontkes

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1365-2141.2011.08683.x

  14. Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group

    Genes, Chromosomes and Cancer

    Volume 54, Issue 12, December 2015, Pages: 809–817, Friederike Braulke, Catharina Müller-Thomas, Katharina Götze, Uwe Platzbecker, Ulrich Germing, Wolf-Karsten Hofmann, Aristoteles A. N. Giagounidis, Michael Lübbert, Peter L. Greenberg, John M. Bennett, Francesc Solé, Marilyn L. Slovak, Kazuma Ohyashiki, Michelle M. Le Beau, Heinz Tüchler, Michael Pfeilstöcker, Barbara Hildebrandt, Carlo Aul, Reinhard Stauder, Peter Valent, Christa Fonatsch, Ulrike Bacher, Lorenz Trümper, Detlef Haase and Julie Schanz

    Version of Record online : 10 SEP 2015, DOI: 10.1002/gcc.22292

  15. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion

    Genes, Chromosomes and Cancer

    Volume 51, Issue 12, December 2012, Pages: 1086–1092, Amel Sebaa, Lionel Ades, Fanny Baran-Marzack, Marie-Joelle Mozziconacci, Dominique Penther, Sophie Dobbelstein, Aspasia Stamatoullas, Christian Récher, Thomas Prebet, Soraya Moulessehoul, Pierre Fenaux and Virginie Eclache

    Version of Record online : 30 AUG 2012, DOI: 10.1002/gcc.21993

  16. You have full text access to this OnlineOpen article
    Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform

    European Journal of Clinical Investigation

    Volume 38, Issue 3, March 2008, Pages: 143–149, P. Valent, O. Krieger, R. Stauder, F. Wimazal, T. Nösslinger, W. R. Sperr, H. Sill, P. Bettelheim and M. Pfeilstöcker

    Version of Record online : 24 JAN 2008, DOI: 10.1111/j.1365-2362.2007.01915.x

  17. You have free access to this content
    Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry

    British Journal of Haematology

    Volume 170, Issue 3, August 2015, Pages: 372–383, Louise de Swart, Alex Smith, Thomas W. Johnston, Detlef Haase, Jackie Droste, Pierre Fenaux, Argiris Symeonidis, Guillermo Sanz, Eva Hellström-Lindberg, Jaroslav Cermák, Ulrich Germing, Reinhard Stauder, Otilia Georgescu, Marius MacKenzie, Luca Malcovati, Mette S. Holm, Antonio M. Almeida, Krzysztof Mądry, Borhane Slama, Agnes Guerci-Bresler, Laurence Sanhes, Odile Beyne-Rauzy, Elisa Luño, David Bowen and Theo de Witte

    Version of Record online : 24 APR 2015, DOI: 10.1111/bjh.13450

  18. You have free access to this content
    Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients

    Cytometry Part B: Clinical Cytometry

    Volume 88, Issue 3, May/June 2015, Pages: 154–164, Wolfgang Kern, Ulrike Bacher, Claudia Haferlach, Tamara Alpermann, Susanne Schnittger and Torsten Haferlach

    Version of Record online : 24 MAR 2015, DOI: 10.1002/cyto.b.21224

  19. You have free access to this content
    Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: Clinicopathologic correlations and new insights from the prelenalidomide era

    American Journal of Hematology

    Volume 83, Issue 9, September 2008, Pages: 708–713, Shernan G. Holtan, Rafael Santana-Davila, Gordon W. DeWald, Rhett P. Khetterling, Ryan A. Knudson, James D. Hoyer, Dong Chen, Curtis A. Hanson, Luis Porrata, Ayalew Tefferi and David P. Steensma

    Version of Record online : 12 JUN 2008, DOI: 10.1002/ajh.21245

  20. You have free access to this content
    Thrombopoiesis-stimulating agents and myelodysplastic syndromes

    British Journal of Haematology

    Volume 169, Issue 3, May 2015, Pages: 309–323, Charlotte K. Brierley and David P. Steensma

    Version of Record online : 6 FEB 2015, DOI: 10.1111/bjh.13285